26,806 official source entries are searchable. Checked 2026-09-22; edition published 2026-09-15.
Printed tariff and statistical lines from this edition, separate from historical WITS averages. Blank duty cells are not a confirmed zero. Review the parent tariff line, general and chapter notes, chapter 99, origin, exclusions, quotas and additional duties. No shipment total or special-rate eligibility is calculated. The edition publication date is not a line-level effective date.
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: › Other, containing alkaloids or derivatives thereof:
Other
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: › Other, containing alkaloids or derivatives thereof: › Other
For veterinary use
Source units: kg
Other
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: › Other, containing alkaloids or derivatives thereof: › Other › Other:
Cardiovascular medicaments
Source units: kg
Other
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: › Other, containing alkaloids or derivatives thereof: › Other › Other: › Medicaments primarily affecting the central nervous system:
Anticonvulsants, hypnotics, and sedatives
Source units: kg
Other
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: › Other, containing alkaloids or derivatives thereof: › Other › Other: › Medicaments primarily affecting the central nervous system:
Antidepressants, tranquilizers and other psychotherapeutic agents
Source units: kg
Other
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: › Other, containing alkaloids or derivatives thereof: › Other › Other: › Medicaments primarily affecting the central nervous system:
Other
Source units: kg
Other
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: › Other, containing alkaloids or derivatives thereof: › Other › Other:
Dermatological agents and local anesthetics
Source units: kg
Other
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: › Other, containing alkaloids or derivatives thereof: › Other › Other:
Medicaments primarily affecting the eyes, ears or respiratory system
Source units: kg
Other
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: › Other, containing alkaloids or derivatives thereof: › Other › Other:
Other
Source units: kg
Other
Reported average: 0%.
Source year: 2023. Classification: HS 2022 (H6). Checked 2026-09-14.
National lines included: 1 of 1. Excluded from the average: 0.
Reported ad-valorem range: 0%–0%.
Reported historical ad-valorem MFN simple average for 2023, not a national tariff schedule. No preferential rates, additional duties, VAT, excise or import permissions are determined.
Not a current 2026 national duty. The HS6 average does not determine the duty of a particular national subdivision, origin or shipment.
WITS observation for this code and year
UN Comtrade H6 descriptions (HS 2022)
WITS API definitions: reported averages and excluded national lines
Direct HS code answer for United States
The source reports an indicative HS6 MFN average of 0.00% (2023 MFN average) for Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine (INN) or norephedrine or their salts; for therapeutic or prophylactic uses, packaged for retail sale.Source status: not assessed. Verify the exact national tariff line, origin treatment, taxes, restrictions, and current customs guidance before using this information in a declaration.
0.00% (2023 MFN average)
not assessed
Import planning
Request a one-page research summary with source checks, landed-cost inputs, and points to verify for HS code 300449 in United States.
Each destination shows its own source label. Oman uses its national schedule; Qatar and UAE entries may cite their separately published references and unresolved exceptions. Other entries retain the historical GCC reference. National codes, duty notes, restrictions and tax treatment can differ; verify with the destination customs authority.
| HS Code | Description | Duty |
|---|---|---|
| 300410 | Medicaments; containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, packaged for retail sale | 0.00% (2023 MFN average)WITS 2023 historical MFN average |
| 300420 | Medicaments; containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | 0.00% (2023 MFN average)WITS 2023 historical MFN average |
| 300431 | Medicaments; containing insulin, for therapeutic or prophylactic uses, packaged for retail sale | 0.00% (2023 MFN average)WITS 2023 historical MFN average |
| 300432 | Medicaments; containing corticosteroid hormones, their derivatives or structural analogues (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | 0.00% (2023 MFN average)WITS 2023 historical MFN average |
| 300439 | Medicaments; containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | 0.00% (2023 MFN average)WITS 2023 historical MFN average |
| 300441 | Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, for therapeutic or prophylactic uses, packaged for retail sale | 0.00% (2023 MFN average)WITS 2023 historical MFN average |
| 300442 | Medicaments; containing alkaloids or their derivatives, containing pseudoephedrine (INN) or its salts, for therapeutic or prophylactic uses, packaged for retail sale | 0.00% (2023 MFN average)WITS 2023 historical MFN average |
| 300443 | Medicaments; containing alkaloids or their derivatives, containing norephedrine or its salts, for therapeutic or prophylactic uses, packaged for retail sale | 0.00% (2023 MFN average)WITS 2023 historical MFN average |
| 300450 | Medicaments; containing vitamins or their derivatives, for therapeutic or prophylactic use, packaged for retail sale | 0.00% (2023 MFN average)WITS 2023 historical MFN average |
| 300460 | Medicaments; containing antimalarial active principles described in Subheading Note 2 to this Chapter, for therapeutic or prophylactic uses, packaged for retail sale | 0.00% (2023 MFN average)WITS 2023 historical MFN average |
| 300490 | Medicaments; consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | 0.00% (2023 MFN average)WITS 2023 historical MFN average |
Data source: WITS/UNCTAD TRAINS (MFN 2022). Values are indicative HS6 MFN averages, not shipment-specific applied rates. Import permission and restrictions are not assessed. Historical reference rates exclude VAT, excise and other national measures. Separate national entries preserve the columns printed by their source; these are not a complete shipment assessment. Full disclaimer.